A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection

References

• Abd El-RahmanAAEl-ShafeiSMIvanovaEVCytotoxicity of Trichoderma spp. cultural filtrate against human cervical and breast cancer cell linesAsian Pac J Cancer Prev201415177229723425227819
   PubMedGoogle Scholar
• JemalABrayFCenterMMGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• ZhangASunHWangXSerum metabolomics as a novel diagnostic approach for disease: a systematic reviewAnal Bioanal Chem201240441239124522648167
   PubMed Web of Science ®Google Scholar
• KangESeongMWParkSKThe prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) studyBreast Cancer Res Treat2015151115716825863477
   PubMed Web of Science ®Google Scholar
• ShiLRacial differences in breast cancer patternsScience201032959873220595598
   PubMed Web of Science ®Google Scholar
• PossematoRMarksKMShaulYDFunctional genomics reveal that the serine synthesis pathway is essential in breast cancerNature2011476736034635021760589
   PubMed Web of Science ®Google Scholar
• LuczynskaEHeinze-PaluchowskaSHendrickEComparison between breast MRI and contrast-enhanced spectral mammographyMed Sci Monit2015211358136725963880
   PubMed Web of Science ®Google Scholar
• LobergMLousdalMLBretthauerMBenefits and harms of mammography screeningBreast Cancer Res20151716325928287
   PubMed Web of Science ®Google Scholar
• AsiagoVMAlvaradoLZShanaiahNEarly detection of recurrent breast cancer using metabolite profilingCancer Res201070218309831820959483
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
   PubMed Web of Science ®Google Scholar
• LocasaleJWVander HeidenMGCantleyLCRewiring of glycolysis in cancer cell metabolismCell Cycle2010921425321045562
   PubMed Web of Science ®Google Scholar
• Vander HeidenMGLocasaleJWSwansonKDEvidence for an alternative glycolytic pathway in rapidly proliferating cellsScience201032959981492149920847263
   PubMed Web of Science ®Google Scholar
• LocasaleJWCantleyLCAltered metabolism in cancerBMC Biol201088820598111
   PubMed Web of Science ®Google Scholar
• GowdaGADjukovicDOverview of mass spectrometry-based metabolomics: opportunities and challengesMethods Mol Biol2014119831225270919
   PubMedGoogle Scholar
• WangXXieYGaoPA metabolomics-based method for studying the effect of yfcC gene in Escherichia coli on metabolismAnal Biochem2014451485524513124
   PubMed Web of Science ®Google Scholar
• WojakowskaAChekanMWidlakPApplication of metabolomics in thyroid cancer researchInt J Endocrinol2015201525876325972898
   PubMed Web of Science ®Google Scholar
• ChahineLMSternMBChen-PlotkinABlood-based biomarkers for Parkinson’s diseaseParkinsonism Relat Disord201420Suppl 1S99S10324262199
   PubMedGoogle Scholar
• GowdaGAZhangSGuHMetabolomics-based methods for early disease diagnosticsExpert Rev Mol Diagn20088561763318785810
   PubMed Web of Science ®Google Scholar
• BathenTFSitterBSjobakkTEMagnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluationCancer Res201070176692669620699363
   PubMed Web of Science ®Google Scholar
• BudcziesJBrockmollerSFMullerBMComparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolismJ Proteomics20139427928824125731
   PubMed Web of Science ®Google Scholar
• JobardEPontoizeauCBlaiseBJA serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancerCancer Lett20143431334124041867
   PubMed Web of Science ®Google Scholar
• KimYKooIJungBHMultivariate classification of urine metabolome profiles for breast cancer diagnosisBMC Bioinformatics201011Suppl 2S420406502
   PubMed Web of Science ®Google Scholar
• AtkinsonKZuckermanBSharfsteinJMA public health response to emerging technology: expansion of the Massachusetts newborn screening programPublic Health Rep2001116212213111847298
   PubMed Web of Science ®Google Scholar
• OmbroneDGiocaliereEForniGExpanded newborn screening by mass spectrometry: new tests, future perspectivesMass Spectrom Rev2016351718425952022
   PubMed Web of Science ®Google Scholar
• HuangZLinLGaoYBladder cancer determination via two urinary metabolites: a biomarker pattern approachMol Cell Proteomics20111010M111
   Web of Science ®Google Scholar
• TusherVGTibshiraniRChuGSignificance analysis of microarrays applied to the ionizing radiation responseProc Natl Acad Sci U S A20019895116512111309499
   PubMed Web of Science ®Google Scholar
• CurtisCShahSPChinSFThe genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature2012486740334635222522925
   PubMed Web of Science ®Google Scholar
• ShahSPRothAGoyaRThe clonal and mutational evolution spectrum of primary triple-negative breast cancersNature2012486740339539922495314
   PubMed Web of Science ®Google Scholar
• KimuraTNoguchiYShikataNPlasma amino acid analysis for diagnosis and amino acid-based metabolic networksCurr Opin Clin Nutr Metab Care2009121495319057187
   PubMed Web of Science ®Google Scholar
• CascinoAMuscaritoliMCangianoCPlasma amino acid imbalance in patients with lung and breast cancerAnticancer Res19951525075107763031
   PubMed Web of Science ®Google Scholar
• KubotaAMeguidMMHitchDCAmino acid profiles correlate diagnostically with organ site in three kinds of malignant tumorsCancer1992699234323481562982
   PubMed Web of Science ®Google Scholar
• MiyagiYHigashiyamaMGochiAPlasma free amino acid profiling of five types of cancer patients and its application for early detectionPLoS One201169e2414321915291
   PubMed Web of Science ®Google Scholar
• HarvieMNCampbellITHowellAAcceptability and tolerance of a low tyrosine and phenylalanine diet in patients with advanced cancer – a pilot studyJ Hum Nutr Diet200215319320212028515
   PubMed Web of Science ®Google Scholar
• JainMNilssonRSharmaSMetabolite profiling identifies a key role for glycine in rapid cancer cell proliferationScience201233660841040104422628656
   PubMed Web of Science ®Google Scholar
• LodiATizianiSKhanimFLProton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies ace-tylcarnitine as a novel marker of active diseasePLoS One201382e5642223431376
   PubMed Web of Science ®Google Scholar
• LadepNGDonaACLewisMRDiscovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West AfricansHepatology20146041291130124923488
   PubMed Web of Science ®Google Scholar
• HuangQTanYYinPMetabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomicsCancer Res201373164992500223824744
   PubMed Web of Science ®Google Scholar
• PooyaSBlaiseSMorenoGMMethyl donor deficiency impairs fatty acid oxidation through PGC-1alpha hypomethylation and decreased ER-alpha, ERR-alpha, and HNF-4alpha in the rat liverJ Hepatol201257234435122521344
   PubMed Web of Science ®Google Scholar
• PutignaniLRaffaSPescosolidoRPreliminary evidences on mitochondrial injury and impaired oxidative metabolism in breast cancerMitochondrion201212336336922366096
   PubMed Web of Science ®Google Scholar
• NeurauterGGrahmannAVKlieberMSerum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8Cancer Lett2008272114114718701209
   PubMed Web of Science ®Google Scholar
• ImashukuSMoriokaYKodoNAbnormal serum phenylalanine-tyrosine ratio and hyperferritinemia in malignant histiocytosisPediatr Hematol Oncol1988542993073152976
   PubMed Web of Science ®Google Scholar
• VizcarraELluchACibrianRValue of CA 15.3 in breast cancer and comparison with CEA and TPA: a study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the first metastasisBreast Cancer Res Treat19963732092168825132
   PubMed Web of Science ®Google Scholar
• ZhengHLuoRCDiagnostic value of combined detection of TPS, CA153 and CEA in breast cancerDi Yi Jun Yi Da Xue Xue Bao2005251012931294129816234113
   PubMedGoogle Scholar